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Abstract
Background: Autism is a heritable developmental disorder of communication and socialization that has
not been well studied in Hispanic populations. Therefore, we are collecting and evaluating all possible cases
of autism from a population isolate in the Central Valley of Costa Rica (CVCR) for a clinical and genetic
study.
Methods: We are assessing all subjects and parents, as appropriate, using the newly translated Spanish
versions of the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation
Schedule (ADOS) as well as tests of intelligence and adaptive behavior. Detailed obstetric and family
medical/psychiatric histories are taken. All cases are tested for Fragile X and will be extensively evaluated
for cytogenetic abnormalities.
Results: To date we have obtained clinical evaluations on over 76 cases of possible autism referred to
our study and report data for the initial 35 complete cases. The mean age of the probands is 6.7 years, and
31 of the 35 cases are male. Twenty-one of the cases have IQs <50 and only 6 cases have IQs ≥ 70. Over
half of the mothers had complications during pregnancy and/or delivery. No cases have tested positively
for Fragile X or PKU. Chromosomal G-banding is not yet complete for all cases.
Conclusion: Diagnostic data gathered on cases of autism in the CVCR using Spanish versions of the ADI-
R and ADOS look similar to that generated by studies of English-speaking cases. However, only 17% of
our cases have IQs within the normal range, compared to the figure of 25% seen in most studies. This
result reflects an ascertainment bias in that only severe cases of autism come to treatment in the CVCR
because there are no government-sponsored support programs or early intervention programs providing
an incentive to diagnose autism. The severity of mental retardation seen in most of our cases may also be
exaggerated by the lack of early intervention programs and the use of IQ tests without Costa Rican norms.
Still, we must formally train healthcare providers and teachers to recognize and refer autistic cases with
normal or near normal IQs that are not seen in treatment.
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Background
Autism (MIM 209850) is a heritable neurodevelopmental
disorder characterized by delayed language acquisition,
impaired socialization, and repetitive or stereotyped
behaviors. Frequent associated features include sensory
abnormalities and lack of motor coordination. The recur-
rence risk for siblings is approximately 30 times that of the
general population, and twin studies have documented a
higher concordance rate in monozygotic (60–91%) than
in dizygotic twins (0–6%) [1]. According to a summary of
32 epidemiological studies, the male:female ratio is ~4:1,
and up to 75% of autistic subjects are mentally retarded to
some degree [2]. Associated medical disorders were esti-
mated to be present in ~6.4 % of autistic individuals in
that review. Four studies also indicate that siblings of
autistic probands are at increased risk for Pervasive Devel-
opmental Disorder Not Otherwise Specified (PDDNOS)
and Asperger's Disorder, suggesting that these disorders
exist on a continuum [3-6]. In fact, a mutation in the Neu-
roligin 3 gene on Xq13 has been identified in a sibship
where one brother has autism and the other has Asperger's
[7]. This mutation was inherited from the mother and
changes a highly conserved arginine residue to cysteine
(R451C), resulting in retention of the protein in the endo-
plasmic reticulum and reduced binding with its presynap-
tic partner beta neurexin-1 [8]. Although mutations in this
gene may not explain a substantial portion of the popula-
tion risk for autism, the finding provides definitive proof
for the genetic basis of autism spectrum disorders (ASD)
and encouragement for ongoing genetic studies such as
ours.
Multiple genes and environmental factors likely contrib-
ute to the etiology of autism, making it difficult to isolate
disease genes. There is a substantial fall-off in risk of
autism for second- and third-degree relatives of autistic
probands [9], and some predict that alleles of 10 to 100 or
more genes, each of small effect, may underlie the autistic
phenotype [10,11]. Hirschprung's disease, or congenital
megacolon, is the prototype of a complex genetic trait and
displays an inheritance pattern that could well be repre-
sentative of autism. To date, there are more than nine sus-
ceptibility genes for this disorder, and different
combinations of alleles interact to produce the pheno-
type. The penetrance of Hirschprung's disease is low, and
the phenotype varies widely in severity within and among
families. This pattern is also seen in the family mentioned
above, where a sibling with autism and a sibling with
Asperger's share at least one identical genetic determinant.
Two principle strategies have been used to try to limit the
genetic heterogeneity underlying such complex pheno-
types. One proven method is to identify more genetically
homogeneous subphenotypes. With respect to autism,
language delay and obsessive compulsive behaviors are
traits that segregate within both affected and unaffected
members of a family [12,13]. In practice, subsetting sam-
ples according to the presence of language delay has
strengthened evidence for linkage to the same regions on
chromosomes 2q and 7q in several different studies [14-
17].
Another, albeit less successful, means of reducing genetic
heterogeneity is to study these disorders in isolated
founder populations. These populations are derived from
a small number of original founders and then grow expo-
nentially, in isolation, such that the small number of dis-
ease alleles introduced by the founders will be widely
distributed in the present day. For instance, genes for Hir-
schprung's disease have been identified in the genetically
isolated population of the old order Mennonites,
although some degree of heterogeneity was present even
in this population [18].
The CVCR is another well known founder population
widely studied by geneticists interested in neuropsychiat-
ric disorders and other complex traits like asthma [19].
The CVCR was founded ~15 generations ago by a small
number of families from southern Spain, and the local,
predominantly female, Amerindians. These assertions,
based largely on civil and church registries, have been con-
firmed at the genetic level using haplotype data from
mitochondrial DNA (mtDNA), Y-chromosome, and auto-
somal markers [20]. Mitochondrial data indicate that the
four major Native American mtDNA lineages are enriched
in females from the CVCR. Data from the Y chromosome
shows that the male ancestry in CVCR is about 0.86 Euro-
pean, with a small contribution from West African and
Amerind populations. Importantly, an isolated founder
population in Antioquia, Colombia shares the same
demographic history as the CVCR, and autism case collec-
tion is currently underway in that region using the same
study protocol as ours. The only published studies of ASD
in an isolated population are ongoing in Finland [21-23].
A comparison of gene diversity between Finland and the
CVCR shows that they are similar at the autosomal level
[20].
Previously, genetic studies of autism were not undertaken
in the CVCR because the Autism Diagnostic Interview-
Revised (ADI-R) [24] and the Autism Diagnostic Observa-
tion Schedule (ADOS) [25], the standard research instru-
ments used to diagnose autism, were available only in
English. Furthermore, application of the ADI-R and ADOS
for research studies requires formal certification training
in English. The ADI-R is a structured diagnostic interview
administered to parents that evaluates social abilities, ver-
bal and non-verbal communication, and repetitive and
stereotyped behaviors in possibly autistic children. In our
population, the test takes anywhere from 2 to 3.5 hours,BMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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depending upon the parent's level of awareness. The
ADOS is a semi-structured standardized assessment of
social interaction, communication, and play that can dis-
tinguish autism and PDDNOS from non-spectrum disor-
ders. The test is 30 minutes long, and one of four modules
is administered to the case, according to their level of
expressive language. Fortunately, a Spanish-language ver-
sion of the ADI-R is now available, and our group partici-
pated in the recent translation of the ADOS.
According to the National Census Register of Costa Rica,
the CVCR harbors approximately 250,000 children
between 0–4 years, another 250,000 between 5–9 years,
and a total of one million individuals under the age of 20,
with a slight preponderance of males in all age groups.
(These numbers represent just under two-thirds of the
totals for the entire country, as that is the estimated per-
centage of people living in the Central Valley). Assuming
that published prevalence estimates in other countries
apply to Costa Rica, as has been documented for
Tourette's Syndrome and Bipolar Disorder [19], and tak-
ing a conservative value of 1 in 1,000 [2] as the prevalence
estimate, there should be ~1,000 cases of autism between
ages 0–20. Given that few cases will be seen before two or
three years of age, and that we require Central Valley
ancestry (not just birth) for entry into the study, the
number of eligible cases may be anywhere from 300–500.
With the appropriate instruments and research-trained
bilingual clinicians, we have begun recruiting autistic sub-
jects and their parents from the CVCR for a genetic study.
The first stage of the genetic study will be to perform
highthroughput cytogenetic screening using a microarray-
based Comparative Genomic Hybridization assay spe-
cially designed to detect microdeletions and duplications
(microdels/dups), including sub-telomeric abnormalities,
too small to be identified by standard karyotyping.
Should we have a suitable sample size of cytogenetically
normal cases after this evaluation, possibly augmented by
samples from the genetically related population in Antio-
quia, we intend to perform a genome-wide single nucleo-
tide polymorphism (SNP) screen to identify autism
susceptibility genes. We also intend to use our samples to
perform fine-mapping of autism loci identified by other
investigators. Here we report complete clinical data gath-
ered on a representative 35 cases recently assessed in the
CVCR. Although this is a preliminary assessment, our
findings related to the problems of IQ testing and recruit-
ment in this population may be helpful to other Latin
American investigators planning similar studies.
Methods
This project was approved under the guidelines of the
Ministry of Health of Costa Rica, the Ethical committee of
the National Children's Hospital in San Jose, and the
Institutional Review Board at Mount Sinai School of Med-
icine. These approvals remain active. All adult participants
provided written informed consent. Parents of participat-
ing minors provided written informed consent; minors
who were capable also provided signed assent.
Translation of the ADOS
Dr. Valeria Nanclares completed a preliminary translation
of the ADOS. She is the Autism Program Coordinator at
the Pediatric Developmental Center, Advocate Illinois
Masonic Medical Center, and also the translator of the
ADI-R. Next, two professional translators read the docu-
ment separately in English and Spanish and documented
instances where the translation was weak or ambiguous.
This approach avoids the introduction of synonyms and
colloquialisms and is thus preferable to simple back-
translation. Subsequently, native Spanish-speaking clini-
cal experts from Latin America and Spain reviewed the
document for content and accuracy of clinical terminol-
ogy and achieved a final consensus with the original trans-
lator. The Latin American expert is Dr. Elina R. Manghi
(ERM), who is also the lead best-estimator for this study.
She is a clinical psychologist and the Clinical Service
Director for the Family Clinic, Department of Disability
and Human Development at the University of Illinois at
Chicago. She has over 20 years of experience in the field
of psychological testing and for the last 10 years has
worked with developmental disorders, including autism.
She is a certified off-site trainer for both the English and
Spanish versions of the ADI-R and is certified for the
research use of the ADOS in the United States. The expert
from Spain was Dr. Amaia Hervas, who has worked exten-
sively with Dr. Michael Rutter's group on various autism
research projects.
Ascertainment of cases
The Hospital Nacional de Ninos (HNN) is located in San
Jose, the capital city of Costa Rica, and is the only major
hospital for children in the CVCR. The HNN has an inpa-
tient Neurodevelopmental Unit and recently added a
small special education school providing services for chil-
dren with mental retardation (MR) and developmental
delay but not specifically autism. All four child psychia-
trists serving the CVCR are also at the HNN. The leading
clinician on our study, Dr. Patricia Jimenez Gonzalez
(PJG), is Chief of the inpatient Neurodevelopmental Unit
at the HNN and has an extensive private practice. She also
has an active relationship with the Autism Parents' Associ-
ation of Costa Rica, a group that is highly motivated to
participate in research and promote community educa-
tion. PJG has passed Dr. Catherine Lord's certification
course for research use of the ADI-R and ADOS.
A recent study showed that the number of autism and
autism spectrum disorder (ASD) cases being diagnosed inBMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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the United States increased precipitously following the
introduction of Federal special education laws that
included autism spectrum disorders as a disability cate-
gory in 1991 [26]. The diagnostic criteria for autism were
also broadened in DSM III-R in 1987 and DSM IV in 1994,
and one study shows that both the changes in the formal
diagnosis of autism, as well as the laws providing Federal
support for children with ASD, can account for the
increased incidence of this disorder in Olmsted County,
Minnesota [27]. Therefore, it is not surprising that aware-
ness of autism is only a recent phenomenon in Costa Rica,
as this country lacks sufficient financial support for treat-
ment of children with ASD. As a result, we began our
recruitment with a list of 245 potential cases known to Dr.
Jimenez from the HNN and her outpatient practice. These
cases were selected because of documented developmen-
tal delay (cognitive/language and motor) and/or
extremely disruptive behaviors characteristic of autism
that lead parents to seek consultation in the first place.
However, we have formulated a strategy to find the cases
of high functioning autism, with normal or near normal
IQ, that are not being seen by clinicians or treatment pro-
viders, or are being seen but not properly diagnosed. For
instance, one study recently reported that an increase in
the diagnosis of ASD between 1983 and 1996 appeared to
be due to greater recognition of ASD in higher functioning
children initially presenting with attention deficit hyper-
activity disorder (ADHD) [28]. Another study surveyed
the medical and psychiatric records of 101 Swedish chil-
dren of normal intelligence (mean age 9 years, 8 months)
diagnosed with PDD, in order to identify cases that might
actually represent high functioning autism, and found
that three-quarters had symptoms compatible with mild
to severe ADHD or problems with attention and motor
control [29]. These children also tended to be doing
poorly in school or to be in special education programs
despite their normal intelligence. Therefore, we will offer
training to child psychiatrists, pediatricians, and special
education teachers, under the auspices of the Costa Rican
Education Ministry, to help them recognize potential
cases of high functioning autism. ERM is actively involved
in providing this training in Illinois. She will demonstrate
this training model, which can be repeated several times a
year. ERM has generated a large number of referrals for
evaluation of autism at her bilingual Spanish Autism
Clinic, which is part of the Family Clinic, Department of
Disability and Human Development, University of Illi-
nois at Chicago. We will also invite members of the
Autism Parent Association of Costa Rica to participate in
this training. We anticipate this training strategy will
increase the awareness of high functioning autism, result-
ing in referrals for the project.
Diagnosis of autism and autism spectrum disorders
Families of individuals with possible autism contact us, or
are contacted by us after expressing interest in the study,
and are formally asked to participate using established
informed consent criteria. They are first screened by PJG
using an abbreviated version of the ADI-R (Autism Screen-
ing Questionnaire) for the presence of symptoms consist-
ent with a developmental disorder, as well as for pertinent
medical information. All interviews and exams take place
in the Neurodevelopmental Unit of the HNN. Possibly
affected individuals and their parents are interviewed by
PJG or Dr. Marietha Fallas Delgado (a pediatrician under
her supervision) using the ADI-R. Either PJG or Sylvia
Monge Monge, M.A., who has a master's degree in psych-
oeducation, administers the ADOS. Both of these assess-
ments are videotaped for independent scoring by the best
estimators.
An IQ score and an adaptive behavior score are required
for the diagnosis of MR. Intelligence is assessed using age
and developmentally appropriate instruments available
in Spanish and currently in use in Costa Rica. However, a
major problem with these IQ tests is that there are often
no norms specific for individual Latin American coun-
tries. A few IQ tests have norms derived in Spain and Mex-
ico, yet, according to Domingo Campos, Director,
Instituto de Investigaciones Psicologicas de la Universi-
dad de Costa Rica (Psychological Research Institute, Uni-
versity of Costa Rica), Costa Rica has no internal data of
its own to assess potential scoring biases that might be
introduced using foreign norms. The tests we use include
the Bayley Scales of Infant Development II (1993) [30]
(0–42 months developmental age), the McCarthy Scales
of Children's Abilities (1972) [31] (2-1/2 to 8-1/2 years),
the Leiter-R (1997) [32] (2 years to 20 years), the Wechsler
Preschool and Primary Scale of Intelligence-Third Edition
(2002) (WPPSI-III) [33], which is divided into two sub-
tests for ages 2:6–3:11 years and 4:0–7:3 years, and the
Wechsler Intelligence Scale for Children, Third Edition
(1991) (WISC III) [34]. The IQ reflects how children
answer verbal reasoning questions and respond to visual-
spatial reasoning tasks. Because language and attention
are impaired in children with autism, assessments of their
IQs are notoriously unreliable. Therefore, we also admin-
ister the Vineland Adaptive Behavior Scales/VABS [35] to
each proband. The VABS is a structured interview of the
parent concerning observed communication and social
and daily living skills at home and in the community.
Both the IQ and VABS are administered by our psycholo-
gist, Licenciada Marcela Esquivel Pla., who was trained in
these instruments by ERM.
Physical examination and laboratory testing
Each autistic proband undergoes a complete physical
examination, including a neurological examination, anBMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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assessment for dysmorphic features, and a dermatological
evaluation. Skin is carefully examined to look for signs of
neurocutaneous disorders, including tuberous sclerosis
(using a Wood's lamp) and hypomelanosis of Ito, as these
disorders are strongly associated with autistic symptoma-
tology. (Of note, one of the world's experts on hypomela-
nosis of Ito is doing a study at the HNN). Probands with
gastrointestinal problems are sent to Internal Medicine for
evaluation as at least one study has shown that an unusual
complement-mediated lymphocytic colitis may be unique
to severely affected autistic subjects [36]. All probands are
karyotyped. Testing of auditory brainstem-evoked
responses is requested in some cases, and computerized
tomography scans are also available on some probands.
Fragile X testing is done on all cases. Phenylketonuria
(PKU) testing is also performed when required, as it was
not instituted as a routine procedure in the CVCR until
~10 years ago.
Medical and social history
Please see the Clinical History form [see Additional file 1]
for complete details of this evaluation. Sources of infor-
mation for medical and social history include parents and
medical records. In brief, we record parental occupational
and educational history, followed by family neuropsychi-
atric history, obstetric data, including any adverse events
during pregnancy and APGAR scores, the developmental
and medical history of the proband, any medication and/
or education the proband has received, and results of the
physical exam and laboratory testing. As the family his-
tory of psychiatric disorders relies on parental report, it
cannot be regarded as fully reliable. Therefore, we try to
validate the diagnoses by asking about hospitalizations
and medication treatments when possible.
In both the immediate and extended family we also spe-
cifically ask about the presence of language delay and
learning deficits, which could be manifestations of the
broader autism phenotype. We also ask about autoim-
mune disorders, as data suggests that at least some of the
autistic phenotype may be induced by autoimmune
mechanisms operating during pregnancy [37].
Verification of genealogy
Don Eduardo Fournier is a Costa Rican historian with
extensive experience in tracing genealogies who collabo-
rates on a majority of the genetic studies in Costa Rica. He
screens the Civil Registry and, if necessary, birth, marriage,
and death records in churches and civic centers to deter-
mine the birthplace of all grandparents and great-grand-
parents. Previous genetic studies in the CVCR have shown
that probands whose great-grandparents were born in the
CVCR will most probably be descendants of the original
Spanish founder population. We require that cases have
six of eight great grandparents born in the CVCR for inclu-
sion in the study.
Best estimate diagnostic process
The ADI-R and ADOS are independently scored by our
bilingual best-estimators, ERM or Pamela Bondy, M.S./
CCC-L (PB). PB is a bilingual speech and language thera-
pist with over 10 years of experience in the field of devel-
opmental disabilities. She was trained in the use of the
ADI-R and ADOS by ERM. Discrepancies, if any, were
resolved and final diagnoses reached after review of collat-
eral historical information, clinical exam, and laboratory
testing, according to standard best-estimate diagnostic
procedure [38].
Results
To date we have ascertained 76 subjects and enrolled 70
families in our study. One family later declined to partic-
ipate because of the mother's health, two cases have been
excluded by genealogy, one case was too retarded to deter-
mine a diagnosis, one case has RETT syndrome (AU043),
and the other excluded case is an autistic child with Moe-
bius syndrome (AU044). We are screening the RETT syn-
drome case for mutations in the MECP2  gene. The
Moebius syndrome case offers fascinating insights into
the etiological basis of autism and will be reported in
detail in a subsequent publication. Extrapolating from the
entire data set of 70 cases, the male to female ratio appears
to be ~6:1. Our goal is to collect over 200 trios, with no
major or minor cytogenetic abnormalities, suitable for
genetic mapping.
As the diagnostic evaluation takes two to three appoint-
ments, we have only complete best-estimated data on 35
cases to date. Karyotypes ordered for cases AU025,
AU031, and AU040, with family histories of MR, and for
case AU001, who has a cleft palate, were all negative at ≥
550 bands. Interestingly, case AU025 and case AU031 are
related to each other by a distance of seven generations,
and a connection with case AU040 has not been ruled out.
Case AU008, suspected of Angelman's syndrome, had one
normal karyotype, and testing for a chromosomal 15q11-
q13 abnormality will be performed. The rest of the karyo-
types are pending.
Table 1 in the text contains abbreviated descriptive statis-
tics on the first complete 35 cases [see Additional file 2].
Ages range from 3 years to 13 years of age, and 31 of the
35 cases are male. Mothers and fathers of the autistic chil-
dren have at least some high school on average. The aver-
age mother is a homemaker and the fathers are skilled
laborers; overall, the socioeconomic status of the parents
is low. The mean total score for the social domain of the
ADI-R is 25.3 ± 5.4 in our sample; the nonverbal and ver-
bal communication domain mean scores are 12.6 ± 1.8BMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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and 17.8 ± 3.4, respectively; and the mean score for the
repetitive behaviors and stereotyped patterns domain is
6.6 ± 2.3. The ADOS module scores reflect the severity of
the ADI-R scores in all cases. Vineland adaptive behavioral
profile composite scores range from 20–80, excluding the
value of 127 for case AU029 with Asperger's, and the
mean score is 48.5 ± 19.4. The majority of full-scale IQ
scores are less than 50. Delayed onset of phrase speech is
present in 24 of the 35 cases.
Table 1: is an abbreviated version of descriptive data obtained for each proband, including their sex and age at interview. Scores for 
each domain of the ADI-R are provided, as well as the full-scale IQ score and the Vineland Adaptive Behavior composite score. The 
superscript numerals next to the IQ score indicate the specific IQ test that was used.
Case Social 
total
Communi-
cation nonverbal 
total
Communi-
cation verbal 
total
Behavior 
total
Age at first 
single 
words
Age at first 
phrases
Gender Age at 
interview 
(ADI-R)
Full-scale IQ Vineland Adaptive 
Behavior composite 
score
001 29 18 10 1 1 M 7.83 496 37
0 0 2 2 9 2 0 500 M 5 . 6 7 < 5 0 8 53
0 0 3 2 8 2 5 601 M 6 . 7 5 8 7 6 60
0 0 4 2 7 1 4 811 M 7 . 5 0 < 5 0 5 30
005 26 22 10 1 1 F 5.42 576 51
0 0 6 9 2 0 511 M 6 . 2 5 6 7 7 54
007 21 20 10 0 1 M 10.00 377 20
0081 2 9 1 2 800 M 5 . 0 8 N A 4 5
0 0 9 2 7 1 9 901 M 8 . 0 8 3 4 7 46
0 1 0 2 7 2 1 501 M 9 . 2 5 4 3 6 35
0 1 1 2 7 1 6 601 M 1 0 . 5 0 N A 5 0
0 1 2 2 0 8 1 4 811 M 5 . 2 5 7 2 7 70
0 1 3 2 91 41 6 6 0 0 M 4 . 3 3 < 5 0 5 44
0 1 4 2 91 31 9 6 1 1 M 6 . 5 0 < 5 0 5 51
0 1 5 3 0 1 4 901 F 5 . 0 3 < 5 0 5 46
0 1 6 2 81 22 0 1 2 1 1 M 1 3 . 0 0 6 0 6 39
0 1 8 2 7 1 1 710 M 3 . 6 7 < 5 0 5 67
0 1 9 2 9 1 7 700 M 7 . 2 5 6 6 6 63
0 2 5 2 8 1 2 800 M 7 . 8 3 < 5 0 5 24
0 2 7 2 4 1 8 611 M 4 . 2 5 < 5 0 5 55
0 2 8 2 9 1 4 301 M 5 . 4 2 < 5 0 5 47
0292 1 6 9 211 M 6 . 8 3 1 1 3 6 127
0 3 0 2 7 1 3 510 M 5 . 6 6 < 5 0 5 43
0 3 1 2 9 1 5 411 M 7 . 0 8 7 0 6 52
0 3 2 1 6 1 1 410 M 5 . 4 2 < 5 0 5 42
0 3 3 1 8 8 600 F 4 . 8 3 < 5 0 5 46
0 3 5 1 8 1 5 511 M 7 . 0 8 < 5 0 5 45
0 3 6 2 9 1 4 300 M 6 . 3 3 < 5 0 5 32
0 3 9 3 0 1 4 500 M 9 . 8 2 < 5 0 5 21
0 4 0 1 5 1 5 511 M 3 . 0 8 7 5 5 80
0 4 9 2 9 1 4 911 M 1 3 . 2 5 < 5 0 5 20
050 21 13 6 1 1 M 2.92 pending 60
0 5 1 3 0 1 4 801 F 5 . 5 0 < 5 0 5 39
0 5 3 2 9 1 8 800 M 5 . 8 3 1 0 5 6 55
056 28 21 7 ? 1 M 6.00 566 49
0433 2 2 1 2 500 F 4 . 8 3 N A 4 1
0444 2 7 1 1 211 F 5 . 7 5 N A 5 0
1Angelman's syndrome
2Asperger's syndrome
3Rett syndrome
4Moebius syndrome
5Bayley
6WPPSI
7Leiter
8McCarthy
NA indicates that the IQ test could not be completed because the child is too mentally retarded or was too distracted.BMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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The Family History of Medical Disorders chart is available
in the supplementary data [see Additional file 3]. AU033
developed epilepsy at the age of 2 years and 9 months, but
is the only proband with this condition. Six of the cases
have minor congenital defects, including a cleft palate,
hip rotation, visual problems, megacisterna magna, and
esophageal reflux/cardiomyopathy. Twelve of the cases
have first- or second-degree relatives with language delay
or learning deficits. Developmental delay or autism is
present in the first-degree or second-degree relatives of
four cases. Four of the cases have a second-degree relative
with non-specific MR, one case has a second-degree rela-
tive with Down's syndrome, five cases have a second-
degree relative with epilepsy, and one case has a sister
with a minor congenital defect (cleft palate). Six cases
have first-degree relatives with a major psychiatric disor-
der, including schizophrenia and major depression. No
cases have tested positively for Fragile X or phenylketonu-
ria, and no history of autoimmune disorder was docu-
mented for any case.
We have obtained extensive obstetric data on our cases
and will be reporting it in full in a subsequent publica-
tion. In brief, although only 4 of the mothers were older
than 35, 21 of them had obstetric complications and/or
the infant had an APGAR score less than 6 at one minute.
Fully twenty of the cases were the product of difficult
labor, resulting in fetal distress and a caesarean section in
eight instances.
Discussion
On the whole, our first cases have mean ADI-R scores
comparable in severity to those of other autism genetic
studies, including a sample from the Autism Genetic
Resource Exchange (AGRE) (N = 364 cases from 212 sib-
ships) [12] and a sample of 43 sibships from the Interna-
tional Molecular Genetic Study of Autism Consortium
[16]. IQ and adaptive behavioral scores were not reported
for the AGRE cases, but our mean VABS composite score
is 48.5 ± 19.4 versus a mean of 47.44 ± 16.15 for the IMG-
SAC cases. However, it is clear that the cases of autism
known to the HNN are more severe than those seen in
other non-Hispanic populations studied recently,
although perhaps not before 1991.
Eighty-three percent of our cases are mentally retarded,
while 60% have IQs <50. In contrast, epidemiological
data from a range of countries, although none of them
Latin American, estimate that 75% of autistic individuals
have IQs <70 and 40% have IQs <50 [2]. However, a
closer look at all the major epidemiological studies to
date, reviewed by Fombonne in 2003, shows that the
median prevalence of autism was only 4.4/10,000, and
the reported percentages of normal IQs were, in general,
lower in studies done before 1991 when there was also
less awareness of autism. In contrast, the median preva-
lence of autism is 12.7/10,000, and the percentages of
normal IQs is increasingly higher, in studies done more
recently. This is in part due to a broader definition and
recognition of autism, but also, at least in the United
States, it is possible that early intervention services, insti-
tuted over 15 years ago, have improved the cognitive per-
formance of autistic children. For instance, some studies
report that cases of autism with low IQs can achieve
marked improvements in intelligence, language, learning,
or visuo-spatial skills [39,40] with a minimum of two
years of intervention [41], although others feel that out-
come measures have not been properly evaluated [42].
Costa Rica now provides some special education services;
however, these are not specific to children with autism
and are not offered to children more than once weekly.
Moreover, teachers are not trained in autism interven-
tions, and many children complete only primary
education.
We must also consider the possibility that the IQs of our
cases are underestimated due to the use of psychometric
tests without Costa Rican norms. A recent study done in
Argentina illustrates the effects of low socioeconomic sta-
tus and lack of internal norms on IQ testing results. This
group set out to perform a longitudinal study of the effects
of poverty and malnutrition on the psychological devel-
opment of children in a province of Buenos Aires [43].
The study took place from 1984 to 1995 and followed 100
children of low socioeconomic status with or without
malnutrition. Cases between ages 0–2 with malnutrition
but without other neurological or medical deficits were
ascertained from an ambulatory Nutritional Rehabilita-
tion Unit of a local hospital and matched with well-nour-
ished cases of the same age and sex from the same
socioeconomic background. A pediatrician, a pediatric
neurologist, a psychologist, and an anthropologist per-
formed the evaluations. Ninety-two children were reas-
sessed at 2 years, and 44 were reassessed at the 10-year
point. Malnutrition was rectified in that group during the
two-year interval between assessments. For the initial
evaluation, the group used the Escala de O. Brunet-I.
Lezine, which is used to assess global psychomotor devel-
opment of 0–2 year olds. At the next two time points, they
used the Terman-Merril (Forma L-M) intelligence test to
obtain IQs. This test was normed on children in the
United States, and there were no norms available for
Argentina.
At the first evaluation, the malnourished children did
have significantly lower developmental quotients than
the well nourished group, the majority of which had nor-
mal ratings. However, at time point 2, after which the
malnourished children had been treated, there was no dif-
ference between groups, but both were lower than theBMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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standard. At time point 3, when the children were ~10
years of age, there was again no difference in IQ between
groups, but ~50% of both groups had IQs = 70. The
authors of the study drew two major conclusions from
these results. The first was that poverty and lack of early
intellectual stimulation had profound effects on IQ, even
without malnutrition, and that these effects became more
prominent with time. The second conclusion concerned
the use of IQ tests without norms reflecting the general
population of Argentina. The raters felt that the IQ scores
of both groups were probably somewhat underestimated
because the norms they were comparing them to were
derived from children with much higher socioeconomic
status. The raters were very experienced in administration
of the IQ tests, which were commonly used at universities
and elsewhere in Argentina, so misuse of the tests was not
an issue. Unfortunately, Latin American governments do
not invest in psychological research, and the corporations
that sell tests in the United States don't see Latin America
as a strong market and thus put no money into norming
translated tests. (We wish to note that Argentina now has
its own norms for some IQ tests but not all.)
As further evidence of problems with IQ testing, and per-
haps ascertainment bias, in the CVCR, we note that in
genetic studies of Tourette's Syndrome and ADHD ongo-
ing in the CVCR, 20–25% of cases evaluated for either
phenotype have been excluded because of MR (PJG,
unpublished data). In contrast, 3.9 % of children with
Tourette's Syndrome (TS) had MR (range 1–14%) in a
large-scale analysis of this disorder in 22 countries (no
specific data for Spanish-speaking countries) [44]. Addi-
tionally, although children with ADHD have, on average,
IQs 7–12 points lower than comparison children, the rate
of MR observed in the CVCR is certainly not characteristic
of ADHD in North America [45,46]. Of course, an ascer-
tainment bias towards severe cases could also explain the
CVCR IQ data for ADHD and TS. However, data concern-
ing the prevalence of epilepsy in autism and ASD also sug-
gests that the IQs of our subjects may be underestimated.
For example, severe MR is often seen in cases of autism
with a comorbid medical disorder. Early seizures, before
two years of age, were present in 60% of this population
in one study, and 20% of autistic subjects with severe MR
but no comorbid medical disorders experienced seizures
before the age of five [47]. As the mean age of our
probands is 6.8 years and only one of them has experi-
enced seizures, it seems less likely that autism is secondary
to other medical factors in the majority of our cases.
Finally, the median male to female sex ratio of 11 previ-
ous epidemiological studies, wherein the majority of cases
were moderately to severely retarded, was 1.9:1, versus
5.75:1 for studies of predominantly normal IQ probands
[2]. We also observe a family history of MR in 4 of our
cases, but our male to female sex ratio is ~6:1 (also true for
the 70 cases collected to date).
Accurate assessment of IQ is important, as data suggests
that that there may be different genetic and environmen-
tal determinants for autism based on level of cognition,
although cases of autism with low IQ may still have a
strong genetic basis. For instance, Baird & August [48]
observed a familial loading in cognitive impairment con-
fined to autistic probands with severe or profound MR. To
determine if autism with severe MR was a distinctly differ-
ent autistic endophenotype associated with increased
familial cognitive impairment, another group [49] stud-
ied 47 autistic probands with an IQ <50 and contrasted
their findings with a sample of 99 autistic subjects, the
majority of whom had IQs >50 [6]. Importantly, they
found that increased loading for ASD was comparable in
both samples, supporting prior evidence that the same
genetic liability applies to autism and ASD within fami-
lies, regardless of IQ level. Interestingly, a recent study
also shows that co-occurrence of lower IQ and ADHD
reflect common genetic determinants and not necessarily
the presence of a primary medical or neurological disor-
der [46].
We do note frequent obstetric complications in our sam-
ple and are researching the rates of these complications in
the CVCR hospitals for comparison. We are also looking
at factors such as geographic distance from a hospital,
which might contribute to suboptimal labor and delivery.
However, recent data suggests that these complications
are commonly associated with autism and ASD. A large-
scale epidemiological study of autism in Western Aus-
tralia found that cases diagnosed with autism, as well as
their unaffected siblings, had more obstetric complica-
tions than a control group [50]. The authors suggest that
the increased prevalence of obstetric complications
among autism cases is most likely due to underlying
genetic factors, possibly exacerbated by environmental
stressors.
There are many possible underlying cytogenetic or other
medical disorders that may be accompanied by autistic
behavior, and the presence of severe MR can make those
cases suspect even if karyotypes are normal. Disturbingly,
a group of investigators recently reported that they found
microdups/dels, as well as other genetic abnormalities, in
272 cases from the Paris Autism Research International
Sibpair (PARIS) sample that had already been included in
genetic linkage and association studies [51]. These include
a 22q11 deletion without the associated features of
DiGeorge/Velocardiofacial syndrome in two autistic
brothers with severe MR, and their mother, as well as
duplications of 15q11-13 (in two different singletons)
and of 17p11.2 and 7q11.2. Therefore, we have developedBMC Psychiatry 2005, 5:15 http://www.biomedcentral.com/1471-244X/5/15
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a collaboration to screen our cases using microarray-based
Comparative Genomic Hybridization technology. We will
hybridize our samples to a whole genome array contain-
ing 2632 BAC (bacterial artificial chromosome) clones at
a resolution of ~1 Mb spanning the 22 autosomes and the
X and Y chromosomes. In this way we will find any known
and novel microdups/dels, as well as subtelomeric abnor-
malities, in our cases before we proceed with any genetic
association analyses. Thus, we feel confident that our
cases, regardless of IQ, will be as free of genetic abnormal-
ities as can be determined given current technology.
Conclusion
We have successfully used the Spanish versions of the
ADI-R and ADOS to diagnose autism for genetic study in
the CVCR. The majority of the cases reported here have IQ
<50. This reflects an ascertainment bias, yet it is also pos-
sible that these scores are artificially low. Nevertheless, we
are most likely missing cases of autism with normal or
near normal IQ due to a lack of government-sponsored
services. Therefore, we are implementing a strategy, used
successfully by one of our clinical experts to find both
English-speaking and Spanish-speaking higher function-
ing autistic subjects in the United States, to ascertain these
cases. We believe that similar problems with IQ testing
and the need for specific strategies to find high function-
ing autism cases will be important issues to address for
studies of autism planned or ongoing in other Latin Amer-
ican countries.
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